ArticleFrontiers in medicine2026

Efficacy and safety of dupilumab in moderate-to-severe atopic dermatitis with stage 3-5 chronic kidney disease: a retrospective real-world study.

Jiali Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.